Skip to main content

Table 1 Patient baseline characteristics of the entire cohort

From: Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma

Variables

 

Median age (range), years

55 (25–77)

Median body mass index (range), kg/m2

22.7 (15.0–32.9)

Site of disease

 Ovary (%)

144 (96%)

 Fallopian tube/peritoneum (%)

6 (4%)

Neo-adjuvant chemotherapy (%)

14 (9.3%)

Preoperative laboratory values

 Median CA-125 (range), U/mL

1166 (57–5502)

 Median total protein (range), g/dL

7.1 (4.1–9.6)

 Median albumin (range), g/dL

3.9 (2.4–8.2)

Tumor stage

 IIIC (%)

114 (76%)

 IV (%)

36 (24%)

Histology

 Serous (%)

134 (89.3%)

 Non-serous (%)

16 (10.7%)

Presence of pleural effusion before surgery (%)

47 (31.3%)

 Right

9 (6.0%)

 Left

9 (6.0%)

 Bilateral

29 (19.3%)

Preoperative pleural drainage (%)

7 (4.7%)

Presence of ascites at surgery (%)

141 (94%)

Median ascites volume (range), mL

2000 (20–7300)

Type of diaphragm surgery

 Diaphragm peritonectomy (%)

124 (82.7%)

 Diaphragm full-thickness resection (%)

26 (17.3%)

  1. Abbreviations: CA-125 cancer antigen 125